Mouridsen Ht
- Oncology top 10%
- Cancer Research top 10%
- Genetics top 10%
- Pathology and Forensic Medicine
- Pulmonary and Respiratory Medicine
- Co-authors
- K FischermanMarianne EwertzH BrinckerTorben PalshofP DombernowskyNiels Nygaard RossingNiels KeidingMikael Rørth
- Topics
- Cancer Treatment and Pharmacology (13 papers)Breast Cancer Treatment Studies (11 papers)Estrogen and related hormone effects (6 papers)
- Cited by
- Cancer ResearchOncologyGenetics
- Journals
- PubMedMunich Personal RePEc Archive (Ludwig Maximilian University of Munich)
- Partner nations
- DenmarkItalyUnited States
In The Last Decade
Mouridsen Ht
32 papers receiving 552 citations
Peers
Comparison fields: 5 of 68
- Oncology 366
- Cancer Research 294
- Genetics 193
- Pathology and Forensic Medicine 95
- Pulmonary and Respiratory Medicine 85
Countries citing papers authored by Mouridsen Ht
This map shows the geographic impact of Mouridsen Ht's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mouridsen Ht with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mouridsen Ht more than expected).
Fields of papers citing papers by Mouridsen Ht
This network shows the impact of papers produced by Mouridsen Ht. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mouridsen Ht. The network helps show where Mouridsen Ht may publish in the future.
Co-authorship network of co-authors of Mouridsen Ht
This figure shows the co-authorship network connecting the top 25 collaborators of Mouridsen Ht. A scholar is included among the top collaborators of Mouridsen Ht based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mouridsen Ht. Mouridsen Ht is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | Adjuvant chemotherapy for premenopausal breast cancer: a meta-analysis using quality-adjusted survival. | 8 |
| 2 | [Mammographic screening in the municipality of Copenhagen. Results of the first screening round]. | 4 |
| 3 | [Treatment of primary breast cancer. Consequences of mammographic screening in the municipality of Copenhagen]. | 3 |
| 4 | [Improved prognosis of breast cancer]. | 5 |
| 5 | [Rationalization profits of radiographic diagnosis with systematic follow-up DBCG (Danish Breast Cancer Cooperative Group) programs. 1]. | 1 |
| 6 | [Prognosis after surgical treatment of breast cancer. 3. The low-risk group of the DBCG (Danish Breast Cancer Cooperative Group)]. | 1 |
| 7 | [Sarcoma treatment in Denmark]. | 3 |
| 8 | Prednimustine in advanced breast cancer: a review. | 4 |
| 9 | Steroid hormone receptors as prognostic indicators in primary breast cancer. | 29 |
| 10 | Adjuvant tamoxifen in postmenopausal high-risk breast cancer patients: present status of Danish Breast Cancer Cooperative Group trials. | 22 |
| 11 | Danish Breast Cancer Cooperative Group (DBCG). Present status and experience. | 8 |
| 12 | Tamoxifen treatment of advanced endometrial carcinoma. A phase II study. | 14 |
| 13 | Organisation of the Danish adjuvant trials in breast cancer. | 77 |
| 14 | Therapeutic effect of tamoxifen versus combined tamoxifen and diethylstilboestrol in advanced breast cancer in postmenopausal women. | 12 |
| 15 | Therapeutic effect of tamoxifen versus tamoxifen combined with medroxyprogesterone acetate in advanced breast cancer in postmenopausal women. | 38 |
| 16 | Clinical trial of rubidazone in solid tumors and malignant lymphomas. | 2 |
| 17 | Danish Breast Cancer Cooperative Group--DBCG. | 67 |
| 18 | [Insulin Monotard and Insulin Lente. Comparison of absorption and clinical effects]. | 5 |
| 19 | The extravascular retention of serum albumin in the operative wound. | 6 |
| 20 | Turnover of human serum albumin before and after operations. | 37 |
About Mouridsen Ht
Mouridsen Ht is a scholar working on Cancer Research, Oncology and Genetics, having authored 34 papers that have together received 615 indexed citations. Recurring topics across this work include Cancer Treatment and Pharmacology (13 papers), Breast Cancer Treatment Studies (11 papers) and Estrogen and related hormone effects (6 papers). The work is most often cited by research in Cancer Research (294 citations), Oncology (366 citations) and Genetics (193 citations). Mouridsen Ht has collaborated with scholars based in Denmark, Italy and United States. Frequent co-authors include K Fischerman, Marianne Ewertz, H Brincker, Torben Palshof, P Dombernowsky, Niels Nygaard Rossing, Niels Keiding, Mikael Rørth, W. Mattsson and K Hou-Jensen. Their work appears in journals such as PubMed and Munich Personal RePEc Archive (Ludwig Maximilian University of Munich).
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.